Mark Dransfield
Expertise in
14
conditions

Dr. Mark Dransfield

Intensive Care Medicine
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham, AL 
Clinical Trials:Currently Recruiting for 1 Trial

Expertise in
14
conditions
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Dransfield is an Intensive Care Medicine provider in Birmingham, Alabama. Dr. Dransfield is highly rated in 14 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, Endoscopy, and Lung Transplant.

His clinical research consists of co-authoring 351 peer reviewed articles and participating in 15 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in AL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

University of Alabama Health Services Foundation PC
2000 6th Ave S, Birmingham, AL 35233
Call: 205-996-5864
Other Locations
Dept of Veteran Affairs
700 19th St S, Birmingham, AL 35233
Call: 205-933-8101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


15 Clinical Trials

The American Lung Association (ALA) Lung Health Cohort
The American Lung Association (ALA) Lung Health Cohort
Enrollment Status: Recruiting
Publish Date: March 26, 2025
Subpopulations and Intermediate Outcome Measures in COPD Study
Subpopulations and Intermediate Outcome Measures in COPD Study
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)
Enrollment Status: Active_not_recruiting
Publish Date: September 17, 2025
Zephyr Valve Registry
Zephyr Valve Registry
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Device
An Observational Study of Beta-Blocker Use in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction
An Observational Study of Beta-Blocker Use in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Other
A Randomized, Double-blind, Phase 2, Placebo Controlled Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The Topic Trial)
A Randomized, Double-blind, Phase 2, Placebo Controlled Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The Topic Trial)
Enrollment Status: Completed
Publish Date: December 12, 2024
Intervention Type: Drug
Study Drug: Ivacaftor
Study Phase: Phase 2
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II
Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD
Enrollment Status: Unknown
Publish Date: June 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative
RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative
Enrollment Status: Completed
Publish Date: April 13, 2023
Intervention Type: Drug
Study Drug: Indacaterol/Glycopyrrolate
Study Phase: Phase 3
A Feasibility Study: A Safety Evaluation of RheOx on Patients With Chronic Bronchitis in the United States
A Feasibility Study: A Safety Evaluation of RheOx on Patients With Chronic Bronchitis in the United States
Enrollment Status: Unknown
Publish Date: May 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
INtervention Study In overweiGHT Patients With COPD
INtervention Study In overweiGHT Patients With COPD
Enrollment Status: Completed
Publish Date: April 07, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS): A Pilot Study
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS): A Pilot Study
Enrollment Status: Completed
Publish Date: March 31, 2022
Intervention Type: Other
Study Phase: Not Applicable
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 19, 2021
Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Enrollment Status: Terminated
Publish Date: January 25, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 14 Less Clinical Trials

351 Total Publications

Census Tract Variability in COPD Emergency Department, Hospitalization, and Readmission Rates in Travis County, Texas.
Census Tract Variability in COPD Emergency Department, Hospitalization, and Readmission Rates in Travis County, Texas.
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: December 15, 2025
View All 351 Publications
Similar Doctors
Expertise in
21
conditions
Dr. Tracy Luckhardt
Intensive Care Medicine
Expertise in
21
conditions
Dr. Tracy Luckhardt
Intensive Care Medicine

University Of Alabama Health Services Foundation PC

2000 6th Ave S, 
Birmingham, AL 
 (0.1 miles away)
205-996-5864
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tracy Luckhardt is an Intensive Care Medicine provider in Birmingham, Alabama. Dr. Luckhardt is highly rated in 21 conditions, according to our data. Her top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, and Pulmonary Fibrosis.

Expertise in
9
conditions
Dr. Tejaswini Kulkarni
Intensive Care Medicine
Expertise in
9
conditions
Dr. Tejaswini Kulkarni
Intensive Care Medicine

UAB Hospital Birmingham

619 19th St S, 
Birmingham, AL 
 (0.2 miles away)
205-934-4011
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Tejaswini Kulkarni is an Intensive Care Medicine provider in Birmingham, Alabama. Dr. Kulkarni has been practicing medicine for over 17 years is highly rated in 9 conditions, according to our data. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy.

Expertise in
15
conditions
Dr. Joseph Barney
Intensive Care Medicine
Expertise in
15
conditions
Dr. Joseph Barney
Intensive Care Medicine

Office

2000 6th Ave S Fl 4, 
Birmingham, AL 
 (0.1 miles away)
205-934-7557
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joseph Barney is an Intensive Care Medicine provider in Birmingham, Alabama. Dr. Barney is highly rated in 15 conditions, according to our data. His top areas of expertise are Sarcoidosis, Acute Interstitial Pneumonia, Lymphangioleiomyomatosis, Lung Transplant, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dransfield's expertise for a condition
ConditionClose
  • Elite
  • Bronchitis
    Dr. Dransfield is
    Elite
    . Learn about Bronchitis.
    See more Bronchitis experts
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Dransfield is
    Elite
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Emphysema
    Dr. Dransfield is
    Elite
    . Learn about Emphysema.
    See more Emphysema experts
  • Distinguished
  • Asthma
    Dr. Dransfield is
    Distinguished
    . Learn about Asthma.
    See more Asthma experts
  • Pneumonia
    Dr. Dransfield is
    Distinguished
    . Learn about Pneumonia.
    See more Pneumonia experts
  • Advanced
  • Bronchiectasis
    Dr. Dransfield is
    Advanced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Bullae
    Dr. Dransfield is
    Advanced
    . Learn about Bullae.
    See more Bullae experts
  • Cerebral Hypoxia
    Dr. Dransfield is
    Advanced
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
  • Cystic Fibrosis
    Dr. Dransfield is
    Advanced
    . Learn about Cystic Fibrosis.
    See more Cystic Fibrosis experts
  • Eosinophilic Asthma
    Dr. Dransfield is
    Advanced
    . Learn about Eosinophilic Asthma.
    See more Eosinophilic Asthma experts
  • Idiopathic Pulmonary Fibrosis
    Dr. Dransfield is
    Advanced
    . Learn about Idiopathic Pulmonary Fibrosis.
    See more Idiopathic Pulmonary Fibrosis experts
View All 9 Advanced Conditions
  • Experienced
  • Acute Interstitial Pneumonia
    Dr. Dransfield is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Alpha-1 Antitrypsin Deficiency (AATD)
    Dr. Dransfield is
    Experienced
    . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
    See more Alpha-1 Antitrypsin Deficiency (AATD) experts
  • Bronchogenic Cyst
    Dr. Dransfield is
    Experienced
    . Learn about Bronchogenic Cyst.
    See more Bronchogenic Cyst experts
  • Endoscopy
    Dr. Dransfield is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Hypersensitivity Pneumonitis
    Dr. Dransfield is
    Experienced
    . Learn about Hypersensitivity Pneumonitis.
    See more Hypersensitivity Pneumonitis experts
  • Interstitial Lung Disease
    Dr. Dransfield is
    Experienced
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Dr. Mark Dransfield
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.